just - evotec biologics: an overview
Watch the webinar
With the acquisition of Just Biotherapeutics towards the end of last year, our webinar from Jim Thomas - EVP and Global Head of Biotherapeutics at Evotec - gives an overview of Just - Evotec Biologics and what this new collaboration means for the future of Evotec.
Jim leads the Just-Evotec Biologics organisation, a fully owned subsidiary of Evotec, and is President of Evotec US Operations.
This webinar discusses -
- The span of the Just platform and how it complements perfectly the significant acumen of Evotec’s small molecule and early and pre-clinical biology and screening efforts
- How the combination of the two organisations creates a powerful company with substantial capabilities from discovery to commercial manufacturing in both large and small molecule therapeutics